Chad A. Reichard, MD

Articles by Chad A. Reichard, MD

Chad Reichard, MD, highlights key takeaways from CREST trial

October 1st 2025

Chad A. Reichard, MD, outlines key findings from the CREST trial, evaluating the combination of sasanlimab plus BCG in patients with high-risk BCG-naïve NMIBC.

Chad Reichard, MD, on the Expanded Access Program for recombinant BCG

ByChad A. Reichard, MD,Hannah Clarke

March 17th 2025

"This certainly does feel like the beginning of the light at the end of the tunnel coming out of the BCG shortage," says Chad A. Reichard, MD.

Chad A. Reichard, MD

Articles by Chad A. Reichard, MD

Chad Reichard, MD, highlights key takeaways from CREST trial

Chad Reichard, MD, on the Expanded Access Program for recombinant BCG

Latest Updated Articles

Trending on Urology Times

FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures

Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC

Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study

BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC

Michael Cookson, MD, discusses new strategies for treatment intensification in prostate cancer